Deeper understanding of malaria parasite sexual development unlocks opportunities to block disease spread

For the first time, the developmental stages of the deadliest human malaria parasite have been mapped in high resolution, allowing researchers to understand this ever-adapting adversary in more detail than previously possible.

The study, published today (2 May) in Science, details the critical developmental stages of the malaria parasite, Plasmodium falciparum, using single-cell RNA sequencing. This gives detailed information on the life stages of this parasite as it matures, changing from an asexual state to a sexual state, which is necessary before the parasite can be transmitted to mosquitoes.

The research from the Wellcome Sanger Institute, the Malaria Research and Training Center (MRTC) in Mali, and other collaborators, adds to the freely available Malaria Cell Atlas¹. The Atlas provides information for researchers worldwide to investigate and generate tools to track the disease.

The novel insights accessible through the Malaria Cell Atlas can also help identify new ways to block the parasite’s development, including through new drugs or vaccines that can prevent transmission.

Malaria is a life-threatening disease with an estimated 249 million cases and 608,000 deaths globally in 2022². It is caused by the Plasmodium parasite, with P. falciparum being the deadliest type of this parasite and the most prevalent on the African continent².

P. falciparum is a single-celled parasite that evolves quickly, making it difficult to develop long-lasting and effective diagnostics, drugs and vaccines to protect against it. Malaria parasites have a huge amount of genetic diversity and people are frequently infected with multiple different parasite strains. In Mali, around 80 per cent of people infected with malaria carry multiple genetically distinct parasite strains³.

Malaria parasites are found in either an asexual or sexually developed form in the human host. Asexual replication in humans is what causes the symptoms of malaria, but to transmit, parasites have to develop and become either a male or female reproductive cell, known as a gametocyte.  

Sexual commitment and development are controlled by transcription factors, which are proteins that regulate gene activity. The mature sexual forms of the parasite circulate in the bloodstream until they are taken up by mosquitoes.

In the latest research, from the Wellcome Sanger Institute and the MRTC in Mali researchers used both long-read and short-read single-cell RNA sequencing to map the sexual development stages of P. falciparum in the laboratory. This allowed them to track the gene expression levels and highlight which genes are involved in each stage of the process.

The team then applied this approach to parasites from blood samples collected from four people naturally infected with malaria in Mali. This is the first time that these technologies have been applied to real-time infection strains at such a high resolution.

By comparing the laboratory data with the natural infection data, the researchers found parasite cell types not previously seen in laboratory strains, highlighting the importance of real-world data.

The team compared different natural P. falciparum strains within each donor to identify genes of interest.

Some of the genes that were overexpressed in particular strains in the sexual development stages are involved in the survival of the parasite in the

ito, including one that plays a role in dampening mosquito immunity. The next step will be to assess the impact these genes have on transmission.

Jesse Rop, co-first author from the Wellcome Sanger Institute, said: “This is the first time that we have been able to map the sexual development stages of malaria parasites in both laboratory and natural strains, allowing us to gain deeper insight into the similarities and differences. Our research uncovered new biology present in the naturally occurring strains that are not seen in laboratory strains, improving our understanding of how malaria develops and spreads.”

Dr Sunil Dogga, co-first author from the Wellcome Sanger Institute, said: “Our research adds to the growing Malaria Cell Atlas, giving a high-quality, open-access genomic resource for researchers worldwide. This high-resolution atlas can be used by scientists to gain a clear understanding of the genes they are investigating, combine research efforts, and help us more effectively prevent, control, and treat malaria. Working together as a scientific community is the only way we are going to successfully control and treat malaria.”

Professor Abdoulaye Djimdé, co-author from the Malaria Research and Training Centre, University of Bamako, Mali, and Honorary Faculty at the Wellcome Sanger Institute, said: “Malaria has a huge global impact, affecting millions of people each year, and attempts to control and treat the disease are quickly overcome by the parasite. Understanding more about the parasite’s life cycle, the genes involved, and the factors that control these, can be vital to ongoing malaria research. Our research highlights key points in the sexual development of the parasite, which if targeted in future drug development could break the cycle of transmission and help minimise the spread.”

Dr Mara Lawniczak, senior author from the Wellcome Sanger Institute, said: “This new focus of the Malaria Cell Atlas project on natural infections coincides with malaria vaccines being used for the first time and a continued rise of drug resistance. Single-cell RNA sequencing gives us a window into parasite gene usage that is not possible with any other approach, while also providing a much clearer understanding of just how genetically diverse parasites are, even within the same person. The Malaria Cell Atlas is a resource we hope will be increasingly useful on the path to malaria elimination.”

ENDS

Contact details:
Rachael Smith

Press Office
Wellcome Sanger Institute
Cambridge, CB10 1SA
Email: press.office@sanger.ac.uk

Notes to Editors:

This research adds to the Malaria Cell Atlas and gives more in-depth insights into the variation of individual malaria parasites, compared to grouping samples together and sequencing in bulk.

1. The Malaria Cell Atlas is an integrated data set that is freely available for the research community to use worldwide to understand the genes they are studying and assist in the development of possible transmission-blocking treatments.  
2. Malaria Fact Sheet. World Health Organization. Available at [Accessed March 2024]
3. Genome-wide SNP analysis of Plasmodium falciparum shows differentiation at drug-resistance-associated loci among malaria transmission settings in southern Mali.

Publication: S. Dogga, J. rop, J. Cudini, et al. (2024) A single cell atlas of sexual development in Plasmodium falciparum. Science. DOI: 10.1126/science.adj4088

Funding: This research was part-funded by the Medical Research Council, Wellcome, and the Wellcome Sanger Institute. A full acknowledgement list can be found in the publication.

Selected websites:

The Malaria Research and Training Center (MRTC)

The Malaria Research and Training Center (MRTC) of the Faculty of Medicine and Odonto-Stomatology (FMOS) and Faculty of Pharmacy (FAPH) of the is one of the largest research centers in Africa with excellence in the epidemiology and biology of vectors and parasites of malaria and other vector-borne diseases such as leishmaniasis, filariasis, arboviruses and tick-borne diseases.

The center has expanded by developing collaborations with several universities and research institutions around the world.

Find out more at www.mrct-parasito.org or follow us on Twitter and LinkedIn.

The Wellcome Sanger Institute

The Wellcome Sanger Institute is a world leader in genomics research. We apply and explore genomic technologies at scale to advance understanding of biology and improve health. Making discoveries not easily made elsewhere, our research delivers insights across health, disease, evolution and pathogen biology. We are open and collaborative; our data, results, tools, technologies and training are freely shared across the globe to advance science.

Funded by Wellcome, we have the freedom to think long-term and push the boundaries of genomics. We take on the challenges of applying our research to the real world, where we aim to bring benefit to people and society.

Find out more at www.sanger.ac.uk or follow us on Twitter, Instagram, Facebook, LinkedIn and on our Blog.

About Wellcome

Wellcome supports science to solve the urgent health challenges facing everyone. We support discovery research into life, health and wellbeing, and we’re taking on three worldwide health challenges: mental health, infectious disease and climate and health.

---

---